Recurrence of macular hole retinal detachment after intravitreal ranibizumab injection for the treatment of choroidal neovascularization from the remaining macular hole edge.
OBJECTIVE
To report a case who had recurrence of macular hole retinal detachment (MHRD) after intravitreal ranibizumab injection (IVR) for the treatment of choroidal neovascularization (CNV) that arose from the damaged retinal pigment epithelium of the remaining macular hole (MH) edge, which had been successfully treated by pars plana vitrectomy (PPV) 15 years previously.


METHODS
A 67-year-old man with previous PPV for MHRD secondary to high myopia in the right eye had been under observation for 15 years after surgery. The retina had been successfully attached, but the MH remained open. He had CNV which arose from the remaining MH edge. IVR was performed for the treatment of CNV. One month after the injection, CNV was contracted but recurrence of MHRD occurred. PPV with an additional internal limiting membrane peeling, removal of the CNV membrane and 20% SF6 gas tamponade was performed. One year after the last surgery, his right retina was attached and the MH was closed successfully.


CONCLUSIONS
We propose that patients who undergo IVR should be carefully maintained and followed up for possible complications including the recurrence of MHRD.
Department of Ophthalmology, Kobe Kaisei Hospital, Kobe, Japan.
Keiko
K
Otsuka
Hisanori
H
Imai
Tsuyoshi
T
Shimoyama
Takayuki
T
Nagai
Shigeru
S
Honda
Atsushi
A
Azumi
Anti-VEGF; Choroidal neovascularization; Intravitreal ranibizumab injection; Lucentis; Macular hole; Retinal detachment